Steward Partners Investment Advisory LLC Raises Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Steward Partners Investment Advisory LLC raised its position in HealthEquity, Inc. (NASDAQ:HQYGet Rating) by 30.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,371 shares of the company’s stock after buying an additional 316 shares during the quarter. Steward Partners Investment Advisory LLC’s holdings in HealthEquity were worth $92,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in HQY. IndexIQ Advisors LLC purchased a new stake in shares of HealthEquity during the fourth quarter worth approximately $27,000. Pinebridge Investments L.P. purchased a new stake in shares of HealthEquity during the fourth quarter worth approximately $31,000. Signaturefd LLC raised its stake in shares of HealthEquity by 44.3% during the first quarter. Signaturefd LLC now owns 954 shares of the company’s stock worth $64,000 after purchasing an additional 293 shares during the last quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main purchased a new stake in shares of HealthEquity during the fourth quarter worth approximately $68,000. Finally, Nisa Investment Advisors LLC raised its stake in shares of HealthEquity by 10.9% during the fourth quarter. Nisa Investment Advisors LLC now owns 3,265 shares of the company’s stock worth $174,000 after purchasing an additional 320 shares during the last quarter. Hedge funds and other institutional investors own 97.44% of the company’s stock.

Wall Street Analyst Weigh In

HQY has been the subject of several research analyst reports. Wells Fargo & Company initiated coverage on HealthEquity in a research report on Monday, April 11th. They issued an “overweight” rating and a $95.00 price objective for the company. TheStreet upgraded HealthEquity from a “d+” rating to a “c-” rating in a research report on Wednesday, April 6th. The Goldman Sachs Group started coverage on HealthEquity in a research report on Tuesday, July 12th. They issued a “sell” rating and a $59.00 price objective for the company. Guggenheim started coverage on HealthEquity in a report on Wednesday, April 6th. They issued a “buy” rating and a $89.00 target price on the stock. Finally, Deutsche Bank Aktiengesellschaft upped their target price on HealthEquity from $66.00 to $67.00 in a report on Wednesday, June 8th. Two equities research analysts have rated the stock with a sell rating and ten have given a buy rating to the company. According to data from MarketBeat, HealthEquity has a consensus rating of “Moderate Buy” and an average target price of $74.33.

HealthEquity Stock Performance

Shares of NASDAQ:HQY opened at $57.67 on Wednesday. HealthEquity, Inc. has a one year low of $36.81 and a one year high of $75.39. The business’s 50-day simple moving average is $62.21 and its 200 day simple moving average is $59.85. The company has a market cap of $4.87 billion, a P/E ratio of -87.38, a PEG ratio of 4.31 and a beta of 0.97.

HealthEquity (NASDAQ:HQYGet Rating) last issued its quarterly earnings data on Monday, June 6th. The company reported $0.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.11 by $0.04. HealthEquity had a positive return on equity of 3.03% and a negative net margin of 7.11%. The firm had revenue of $205.68 million during the quarter, compared to analyst estimates of $202.72 million. During the same quarter last year, the firm earned $0.25 EPS. Analysts predict that HealthEquity, Inc. will post 0.66 earnings per share for the current year.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, COO Edward Bloomberg sold 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, June 9th. The stock was sold at an average price of $63.31, for a total transaction of $94,965.00. Following the completion of the sale, the chief operating officer now owns 60,850 shares in the company, valued at approximately $3,852,413.50. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. 2.80% of the stock is owned by insiders.

HealthEquity Profile

(Get Rating)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Further Reading

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Want More Great Investing Ideas?

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.